Published in J Clin Microbiol on June 01, 1990
Applications of cellular fatty acid analysis. Clin Microbiol Rev (1991) 2.72
Assignment of CDC weak oxidizer group 2 (WO-2) to the genus Pandoraea and characterization of three new Pandoraea genomospecies. J Clin Microbiol (2001) 1.67
Oligonucleotide primers designed to differentiate pathogenic pseudomonads on the basis of the sequencing of genes coding for 16S-23S rRNA internal transcribed spacers. Clin Diagn Lab Immunol (1995) 1.61
Typing of strains from a single-source outbreak of Pseudomonas pickettii. J Clin Microbiol (1993) 1.58
Ralstonia spp.: emerging global opportunistic pathogens. Eur J Clin Microbiol Infect Dis (2013) 1.34
CDC group O-3: phenotypic characteristics, fatty acid composition, isoprenoid quinone content, and in vitro antimicrobic susceptibilities of an unusual gram-negative bacterium isolated from clinical specimens. J Clin Microbiol (1998) 0.83
Native Valve Endocarditis due to Ralstonia pickettii: A Case Report and Literature Review. Case Rep Infect Dis (2015) 0.77
Cellular fatty acids and metabolic products of Pseudomonas species obtained from clinical specimens. J Clin Microbiol (1976) 3.94
Subgrouping of Pseudomonas cepacia by cellular fatty acid composition. J Clin Microbiol (1989) 2.23
Recovery of Pseudomonas gladioli from respiratory tract specimens of patients with cystic fibrosis. J Clin Microbiol (1989) 2.15
Pseudomonas cepacia: an emerging pathogen in chronic granulomatous disease. J Pediatr (1986) 1.79
Cellular fatty acid composition of Pseudomonas marginata and closely associated bacteria. J Clin Microbiol (1983) 1.40
Association of Pseudomonas cepacia with chronic granulomatous disease. J Clin Microbiol (1975) 1.25
Disorders of phagocyte function. Annu Rev Immunol (1987) 1.16
Rochalimaea henselae sp. nov., a cause of septicemia, bacillary angiomatosis, and parenchymal bacillary peliosis. J Clin Microbiol (1992) 5.62
A newly recognized fastidious gram-negative pathogen as a cause of fever and bacteremia. N Engl J Med (1990) 4.46
In vitro activity of CI-919 (AT-2266), an oral antipseudomonal compound. Antimicrob Agents Chemother (1983) 4.00
Endocarditis caused by Rochalimaea quintana in a patient infected with human immunodeficiency virus. J Clin Microbiol (1993) 2.85
Bartonella (Rochalimaea) quintana bacteremia in inner-city patients with chronic alcoholism. N Engl J Med (1995) 2.74
Polymerase chain reaction-based restriction fragment length polymorphism analysis of a fragment of the ribosomal operon from Rochalimaea species for subtyping. J Clin Microbiol (1993) 2.41
Antimicrobial susceptibility testing of Mycobacterium fortuitum complex. Antimicrob Agents Chemother (1979) 2.40
Identification of toxigenic Clostridium difficile by counterimmunoelectrophoresis. J Clin Microbiol (1980) 2.24
Subgrouping of Pseudomonas cepacia by cellular fatty acid composition. J Clin Microbiol (1989) 2.23
Multicenter evaluation of the Cepheid Xpert methicillin-resistant Staphylococcus aureus (MRSA) test as a rapid screening method for detection of MRSA in nares. J Clin Microbiol (2009) 2.20
Rochalimaea henselae causes bacillary angiomatosis and peliosis hepatis. Arch Intern Med (1992) 2.20
Relationship between superoxide dismutase and pathogenic mechanisms of Listeria monocytogenes. Infect Immun (1979) 2.15
Recovery of Pseudomonas gladioli from respiratory tract specimens of patients with cystic fibrosis. J Clin Microbiol (1989) 2.15
Bacteremia due to Rochalimaea henselae in a child: practical identification of isolates in the clinical laboratory. J Clin Microbiol (1993) 1.82
Prevalence of thymidine-dependent Staphylococcus aureus in patients with cystic fibrosis. J Clin Microbiol (1987) 1.80
Nosocomial acquisition of Burkholderia gladioli in patients with cystic fibrosis. Am J Respir Crit Care Med (1997) 1.79
Activities of various beta-lactams and aminoglycosides, alone and in combination, against isolates of Pseudomonas aeruginosa from patients with cystic fibrosis. Antimicrob Agents Chemother (1982) 1.74
Comparison of sedimentation and flotation techniques for identification of Cryptosporidium sp. oocysts in a large outbreak of human diarrhea. J Clin Microbiol (1985) 1.73
The organism causing bacillary angiomatosis, peliosis hepatis, and fever and bacteremia in immunocompromised patients. N Engl J Med (1991) 1.72
Evaluation of a lysis direct plating method for pediatric blood cultures. J Clin Microbiol (1985) 1.61
Experimental infection of young specific pathogen-free cats with Bartonella henselae. J Infect Dis (1997) 1.61
Frequency of unrecognized Bordetella pertussis infections in adults. Clin Infect Dis (1995) 1.59
Rhodococcus equi infections of humans. 12 cases and a review of the literature. Medicine (Baltimore) (1994) 1.54
Evaluation of Bactogen and Phadebact for detection of Haemophilus influenzae type b antigen in cerebrospinal fluid. J Clin Microbiol (1982) 1.50
Evaluation of the Phadebact CSF test for detection of the four most common causes of bacterial meningitis. J Clin Microbiol (1983) 1.40
Septicemia and meningitis caused by Helicobacter cinaedi in a neonate. J Clin Microbiol (1993) 1.39
Murine antibody responses distinguish Rochalimaea henselae from Rochalimaea quintana. J Clin Microbiol (1992) 1.34
Antimicrobial susceptibility testing of Streptococcus pneumoniae by micro-broth dilution. Antimicrob Agents Chemother (1980) 1.30
Aeromonas-associated gastroenteritis in children. Pediatr Infect Dis J (1988) 1.29
Invasive pneumococcal disease in central Oklahoma: emergence of high-level penicillin resistance and multiple antibiotic resistance. Pneumococcus Study Group. J Infect Dis (1993) 1.24
Detection of Bartonella (Rochalimaea) quintana by routine acridine orange staining of broth blood cultures. J Clin Microbiol (1994) 1.23
Is Clostridium difficile pathogenic in infants? J Pediatr (1982) 1.19
Susceptibility of group A beta-hemolytic Streptococcus isolates to penicillin and erythromycin. Antimicrob Agents Chemother (1981) 1.17
In vitro antibacterial activities of antibiotics against Pseudomonas aeruginosa in peritoneal dialysis fluid. Antimicrob Agents Chemother (1985) 1.12
Immunocytochemical identification of Rochalimaea henselae in bacillary (epithelioid) angiomatosis, parenchymal bacillary peliosis, and persistent fever with bacteremia. Am J Surg Pathol (1992) 1.12
Antimicrobial susceptibility of Aeromonas species isolated from patients with diarrhea. Antimicrob Agents Chemother (1986) 1.11
Clinical characteristics, pathophysiology, and management of hydrocarbon ingestion: case report and review of the literature. Pediatr Emerg Care (1987) 1.08
Evidence of reproductive failure and lack of perinatal transmission of Bartonella henselae in experimentally infected cats. Vet Immunol Immunopathol (1998) 1.08
In vitro activity of antibiotics commonly used in the treatment of otitis media against Streptococcus pneumoniae isolates with different susceptibilities to penicillin. Antimicrob Agents Chemother (1982) 1.07
Differentiation of Haemophilus spp. in Respiratory isolate cultures by an indole spot test. J Clin Microbiol (1982) 1.06
Prevalence of Cryptosporidium parvum infection in children along the Texas-Mexico border and associated risk factors. Am J Trop Med Hyg (2000) 0.99
Fasle-positive macroscopic appearance of blood cultures in sorbitol-containing hypertonic medium. J Clin Microbiol (1979) 0.98
Recognition of Staphylococcus saprophyticus in urine cultures by screening colonies for production of phosphatase. J Clin Microbiol (1985) 0.96
Cat scratch disease: the rare role of Afipia felis. J Clin Microbiol (1998) 0.94
Effect of abrogation of natural killer cell activity on the course of candidiasis induced by intraperitoneal administration and gastrointestinal candidiasis in mice with severe combined immunodeficiency. Infect Immun (1993) 0.93
A multicenter comparison of related pharmacologic features of cephalexin and dicloxacillin given for two months to young children with cystic fibrosis. Pediatr Pharmacol (New York) (1985) 0.93
Comparison of lysis-direct plating and broth methods for pediatric blood cultures: clinical relevance and cost effectiveness. Pediatr Infect Dis (1985) 0.92
Microbiology of recently treated acute otitis media compared with previously untreated acute otitis media. Pediatr Infect Dis (1986) 0.92
Sputum screening by Nomarski interference contrast microscopy. J Clin Microbiol (1979) 0.91
Campylobacter enteritis. A 3-year experience. Clin Pediatr (Phila) (1984) 0.91
Use of ketamine in asthmatic children to treat respiratory failure refractory to conventional therapy. Crit Care Med (1986) 0.90
Synergistic action of amphotericin B and rifampin against Rhizopus species. Antimicrob Agents Chemother (1987) 0.90
Cryptosporidium parvum infection after abrogation of natural killer cell activity in normal and severe combined immunodeficiency mice. J Parasitol (1993) 0.90
Evidence of hydrophobic domains in human respiratory mucins. Effect of sodium chloride on hydrophobic binding properties. Biochemistry (1990) 0.89
Catalase-negative listeria monocytogenes causing meningitis in an adult. Clinical and laboratory features. Am J Clin Pathol (1991) 0.89
Suppression of recurrent genital herpes simplex virus infection with recombinant alpha 2 interferon. J Infect Dis (1986) 0.89
Neutralization of the inhibitory effect of sodium polyanetholesulfonate on Neisseria meningitidis in blood cultures processed with the Du Pont Isolator System. J Clin Microbiol (1984) 0.89
Evaluation of the automated Bact-Alert system for pediatric blood culturing. Am J Clin Pathol (1995) 0.88
Occupational risk of HIV, HBV and HSV-2 infections in health care personnel caring for AIDS patients. Am J Public Health (1987) 0.87
A Cryptosporidium parvum genomic region encoding hemolytic activity. Infect Immun (1995) 0.87
Lipoid pneumonia secondary to baby oil aspiration: a case report and review of the literature. Pediatr Emerg Care (1985) 0.86
Morphologically variable bacilli of cat scratch disease are identified by immunocytochemical labeling with antibodies to Rochalimaea henselae. Am J Clin Pathol (1994) 0.86
Immune response of neonatal specific pathogen-free cats to experimental infection with Bartonella henselae. Vet Immunol Immunopathol (1999) 0.85
Growth hormone improves weight velocity and height velocity in prepubertal children with cystic fibrosis. Horm Metab Res (1998) 0.85
Production and characterization of monoclonal antibodies to purified deglycosylated cystic fibrosis respiratory mucin: evidence for the presence of four immunologically distinct epitopes. Hybridoma (1991) 0.84
Evaluation of an enzyme immunoassay for detection of Neisseria gonorrhoeae in an adolescent population. JAMA (1984) 0.84
Diagnosis of bacterial infections of the newborn infant. Clin Perinatol (1981) 0.84
Middle ear effusion amoxicillin concentrations in acute otitis media. Pediatr Infect Dis J (1998) 0.83
In vitro antimicrobial activity of aztreonam alone and in combination against bacterial isolates from pediatric patients. Antimicrob Agents Chemother (1984) 0.82
Physicochemical characterization of a minor mucin component from cystic fibrosis tracheobronchial secretions. Biochim Biophys Acta (1991) 0.81
Cefoperazone: regression analysis, disk content, and disk susceptibility testing considerations. Antimicrob Agents Chemother (1982) 0.80
Bovine humoral immune response to Cryptosporidium parvum. J Clin Microbiol (1992) 0.80
Effect of inoculum size on Haemophilus influenzae type b susceptibility to new and conventional antibiotics. Antimicrob Agents Chemother (1983) 0.80
Suppurative infections in children caused by non-beta-hemolytic members of the Streptococcus milleri group. Pediatr Infect Dis J (1995) 0.80
Bactericidal activity of cefoperazone in comparison with other beta-lactam antibiotics and gentamicin. Clin Ther (1980) 0.80
Therapy with atovaquone for Cryptosporidium parvum infection in neonatal severe combined immunodeficiency mice. J Infect Dis (1993) 0.79
Recurrent Bipolaris sinusitis following surgical and antifungal therapy. Pediatr Infect Dis J (1987) 0.79
Polymeric structure of human respiratory mucin: studies on two protein components released upon reduction of disulfide bonds. Biochim Biophys Acta (1990) 0.78
Potential permanent respiratory sequela of Stevens-Johnson syndrome in an adolescent. J Adolesc Health Care (1985) 0.78
In vitro activity of moxalactam and cefoperazone against Streptococcus pneumoniae with differing susceptibilities to penicillin. Chemotherapy (1982) 0.77
Experimental cryptosporidiosis in adult and neonatal rabbits. Vet Parasitol (1997) 0.77
Effect on airway resistance of ketamine by aerosol in guinea pigs. Anesth Analg (1989) 0.77
Protozoal colonization of the intestinal tract in institutionalized Romanian children. Clin Infect Dis (1996) 0.76
Aeromonas species in aquaria: a reservoir of gastrointestinal infections? J Hosp Infect (1989) 0.76
Dyskinetic cilia syndrome: clinical, radiographic and scintigraphic findings. Pediatr Radiol (1987) 0.76
Use of preserved organisms for individual test-use quality control of bacterial typing antisera. J Clin Microbiol (1980) 0.75
A high-resolution record of holocene climate change in speleothem calcite from cold water cave, northeast iowa. Science (1992) 0.75
Modal analysis of linear Talbot-cavity semiconductor lasers. Opt Lett (1991) 0.75
Automated phase sensing and control of an external Talbot cavity laser with phase-contrast imaging. Appl Opt (1994) 0.75
Home care: a better alternative for the ventilator-dependent child. J Okla State Med Assoc (1985) 0.75
12.5-W continuous-wave monolithic laser-diode arrays. Opt Lett (1988) 0.75
Broadly tunable laser-diode-based mid-infrared source with up to 31 microW of power at 4.3-microm wavelength. Opt Lett (1996) 0.75